Skip to main content

Table 1 Clinical features of colorectal cancer patients

From: Two precision medicine predictive tools for six malignant solid tumors: from gene-based research to clinical application

 

TCGA cohort

GSE17538

P-value

Number [n]

428

231

NA

Death [n(%)]

98 (22.9)

93 (40.3)

< 0.001

Total survival time (mean ± SD, month)

29.8 ± 25.6

47.6 ± 30.6

< 0.001

Survival time for dead patients (month)

23.3 ± 22.7

26.8 ± 22.0

< 0.001

Survival time for living patients (month)

31.7 ± 26.1

61.7 ± 27.5

< 0.001

Age (mean ± SD, year)

66.5 ± 13.0

64.8 ± 13.4

0.100

Male [(n)%]

230 (53.7)

121 (52.4)

0.739

AJCC stage (IV/III/II/I/NA)

60/124/163/70/11

56/75/72/28/0

< 0.001

AJCC PT (T1/T0/NA)

51/294/72/11/0

NA

NA

AJCC PN (N2/N1/N0/NA)

76/103/249/0

NA

NA

AJCC PM (M2/M1/M0/NA)

47/60/315/6

NA

NA

Lymphovascular invasion (yes/no/NA)

148/237/43

NA

NA

Vascular invasion (yes/no/NA)

89/281/58

NA

NA

Residual tumor (3/2/1/0/NA)

23/21/4/307/73

NA

NA

Perineural invasion (yes/no/NA)

45/126/257

NA

NA

Grade (1/0/NA)

NA

55/144/32

NA

  1. SD standard deviation, NA missing data, AJCC American Joint Committee on Cancer